Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Made-to-measure treatment battling colon cancer by computer

21.04.2006


Colon cancer treatment could be revolutionised with a pioneering computer system to help doctors fight the disease.



Colon cancer is the third biggest killer cancer and the £2 million EU-funded project could mean faster and more accurate diagnosis, leading to better treatment outcomes for patients.

The system identifies gene mutations that contribute to the growth of cancerous tumours, giving doctors vital details about the type of cancer and its possible causes. It works by matching information from a simple blood test to gene databases of other cases, equipping doctors with a valuable tool to make decisions on long-term care.


It helps them determine the most effective way to battle the condition and, by speeding up the time to make treatment decisions, it will boost survival rates and reduce costs incurred by inaccurate diagnosis. It also means patients will no longer need to undergo invasive procedures unnecessarily.

The project has been masterminded by a team across the EU, comprising leading computer experts working alongside cancer specialists, biomedical scientists and genetic engineers.

It heralds the first major step towards tailor-made, personalised medical treatment.

Dr Babak Akhgar leads the seven-strong team working on the project, in the University’s Cultural, Communication and Computing Research Institute. He said: "It’s very exciting. It is potentially a defining IT project for the future of cancer care and is a huge step towards cutting cancer rates across the board because once the system is established it can be adapted to be applied to other cancers. There’s a real chance of helping save lives. It harnesses the know-how in this field across Europe, bringing it to the desktop of any healthcare professional. It means treatment is backed up by hard facts, rather than reliant on a specialist’s interpretation and experience alone.

"It will be the first breakthrough in personalised medicine. It’s like being able to take a tablet not just for symptom relief, but to treat the exact illness you have. This paves the way for 25th century drugs that are tailor-made to treat an individual’s problems, rather than mass-produced drugs for all."

Sheffield Hallam University is one of eight research partners from across Europe working on the project, called MATCH. The state-of-the-art technology could be in use in hospitals within five years.

The next phase of MATCH is collecting data from colon cancer patient databases in Italy and Poland, which will be fed into the system and tested.

Pharmaceutical firms will also be brought into the project to feed into talks on potential new drug design and discoveries.

Kelly Hill | alfa
Further information:
http://www.shu.ac.uk/news

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>